TGTX peer analysis
TG Therapeutics (TGTX) against its competitors: price, today's move, 1-year return and market value side by side.
- TGTX's peers: ADAG (Adagene), ADCT (ADC Therapeutics), CLDX (Celldex Therapeutics), CRVS (Corvus Pharmaceuticals), GMAB (Genmab), IPHA (Innate Pharma), MGNX (MacroGenics), XNCR (Xencor).
TGTX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ADAG Adagene | $2.01 | 10.44% | 11.05% | $75.67M |
| ADCT ADC Therapeutics | $1.28 | -1.54% | -68.16% | $180.05M |
| CLDX Celldex Therapeutics | $27.40 | -2.00% | 9.95% | $2.15B |
| CRVS Corvus Pharmaceuticals | $9.67 | -3.40% | 8.65% | $815.69M |
| GMAB Genmab | $50.02 | -2.59% | 63.62% | $30.84B |
| IPHA Innate Pharma | $0.94 | -8.75% | -47.78% | $104.99M |
| MGNX MacroGenics | $1.98 | -0.01% | 39.43% | $126.53M |
| XNCR Xencor | $33.24 | -2.26% | 110.78% | $2.49B |
| TGTX TG Therapeutics | $63.21 | -2.57% | 108.41% | $9.55B |